Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19

doi:10.1111/all.14420

Comment

. 2020 Oct;75(10):2703-2704.

doi: 10.1111/all.14420. Epub 2020 Jun 12.

Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19

Affiliations

¹ Clinic of Pulmonology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
² Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
³ Pulmonology Department, Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁴ Department of Intensive Care, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁵ Clinic of Infectious Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁶ Sechenov First Moscow State Medical University, Moscow, Russian Federation.

PMID: 32455491
PMCID: PMC7283669
DOI: 10.1111/all.14420

Comment

Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19

Sergey Avdeev et al. Allergy. 2020 Oct.

. 2020 Oct;75(10):2703-2704.

doi: 10.1111/all.14420. Epub 2020 Jun 12.

Affiliations

¹ Clinic of Pulmonology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
² Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
³ Pulmonology Department, Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁴ Department of Intensive Care, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁵ Clinic of Infectious Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁶ Sechenov First Moscow State Medical University, Moscow, Russian Federation.

PMID: 32455491
PMCID: PMC7283669
DOI: 10.1111/all.14420

No abstract available

Keywords: COPD; asthma; infections.

PubMed Disclaimer

Conflict of interest statement

Dr Avdeev, Dr Moiseev, Dr Brovko, Dr Yavorovskiy, Dr Umbetova, Dr Akulkina, Dr Tsareva, Dr Merzhoeva, Dr Gainitdinova, and Dr Fomin have nothing to disclose.

Comment on

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, Zhang C, Yue J, Zhang Z, Renz H, Liu X, Xie J, Xie M, Zhao J. Li X, et al. J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12. J Allergy Clin Immunol. 2020. PMID: 32294485 Free PMC article.

Cited by

Inhaled corticosteroids for the treatment of COVID-19.
Bafadhel M, Faner R, Taillé C, Russell REK, Welte T, Barnes PJ, Agustí A. Bafadhel M, et al. Eur Respir Rev. 2022 Nov 29;31(166):220099. doi: 10.1183/16000617.0099-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36450371 Free PMC article. Review.
Implications of preexisting asthma on COVID-19 pathogenesis.
Ramakrishnan RK, Al Heialy S, Hamid Q. Ramakrishnan RK, et al. Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L880-L891. doi: 10.1152/ajplung.00547.2020. Epub 2021 Mar 24. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 33759572 Free PMC article. Review.
Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019.
Fung M, Otani I, Pham M, Babik J. Fung M, et al. Ann Allergy Asthma Immunol. 2021 Apr;126(4):321-337. doi: 10.1016/j.anai.2020.11.021. Epub 2020 Dec 11. Ann Allergy Asthma Immunol. 2021. PMID: 33310180 Free PMC article. Review.
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.
Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, Comberiati P, Apfelbacher C, Genuneit J, Avdeev S, Kapustina V, Guekht A, Fomin V, Svistunov AA, Timashev P, Subbot VS, Royuk VV, Drake TM, Hanson SW, Merson L, Carson G, Horby P, Sigfrid L, Scott JT, Semple MG, Warner JO, Vos T, Olliaro P, Glybochko P, Butnaru D; Sechenov StopCOVID Research Team. Munblit D, et al. Clin Exp Allergy. 2021 Sep;51(9):1107-1120. doi: 10.1111/cea.13997. Epub 2021 Aug 12. Clin Exp Allergy. 2021. PMID: 34351016 Free PMC article. Clinical Trial.
A phenome-wide investigation of risk factors for severe COVID-19.
Baranova A, Cao H, Teng S, Zhang F. Baranova A, et al. J Med Virol. 2023 Jan;95(1):e28264. doi: 10.1002/jmv.28264. Epub 2022 Nov 8. J Med Virol. 2023. PMID: 36316288 Free PMC article.

See all "Cited by" articles

References

1. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. J Allerg Clin Immunol. 2020;S0091‐6749(20)30495‐4. 10.1016/j.jaci.2020.04.006 [Epub ahead of print]. - DOI - PMC - PubMed
1. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75:1730‐1741. 10.1111/all.14238. - DOI - PubMed
1. Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory‐confirmed coronavirus disease 2019 ‐ COVID‐NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458‐464. - PMC - PubMed
1. Gold JA, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID‐19 – Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:545‐550. 10.15585/mmwr.mm6918e1externalicon - DOI - PMC - PubMed
1. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID‐19: evidence from meta‐analysis. Aging. 2020;12:6049‐6057. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

Russian Academic Excellence Project 5-100/International

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

[1] Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. J Allerg Clin Immunol. 2020;S0091‐6749(20)30495‐4. 10.1016/j.jaci.2020.04.006 [Epub ahead of print]. - DOI - PMC - PubMed

[2] Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. J Allerg Clin Immunol. 2020;S0091‐6749(20)30495‐4. 10.1016/j.jaci.2020.04.006 [Epub ahead of print]. - DOI - PMC - PubMed

[3] Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75:1730‐1741. 10.1111/all.14238. - DOI - PubMed

[4] Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75:1730‐1741. 10.1111/all.14238. - DOI - PubMed

[5] Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory‐confirmed coronavirus disease 2019 ‐ COVID‐NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458‐464. - PMC - PubMed

[6] Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory‐confirmed coronavirus disease 2019 ‐ COVID‐NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458‐464. - PMC - PubMed

[7] Gold JA, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID‐19 – Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:545‐550. 10.15585/mmwr.mm6918e1externalicon - DOI - PMC - PubMed

[8] Gold JA, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID‐19 – Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:545‐550. 10.15585/mmwr.mm6918e1externalicon - DOI - PMC - PubMed

[9] Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID‐19: evidence from meta‐analysis. Aging. 2020;12:6049‐6057. - PMC - PubMed

[10] Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID‐19: evidence from meta‐analysis. Aging. 2020;12:6049‐6057. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19

Affiliations

Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical